Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EDUCATE: a Prospective, Multi-center Study Designed to Collect Real-world Safety and Clinical Outcomes in Subjects Receiving One or More Endeavor Zotarolimus-Eluting Stents and Either Clopidogrel and Aspirin or Prasugrel and Aspirin as Part of a Dual Antiplatelet Therapy (DAPT) Drug Regimen

NCT01069003 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT01069003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01069003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EDUCATE: a Prospective, Multi-center Study Designed to Collect Real-world Safety and Clinical Outcomes in Subjects Receiving One or More Endeavor Zotarolimus-Eluting Stents and Either Clopidogrel and Aspirin or Prasugrel and Aspirin as Part of a Dual Antiplatelet Therapy (DAPT) Drug Regimen
Lead sponsor
Medtronic Vascular
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2010
Completion date
April 30, 2014
Enrollment
2,272 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease